Gene · 2046
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the effect of Yinzhihuang granules on alcoholic liver disease based on pharmacodynamics, network pharmacology and molecular docking. | Chin Med | 2023 | 37165407 | PubTator, text mining | PubMed |
| Immunochemotherapy achieved a complete response for metastatic adenocarcinoma of unknown primary based on gene expression profiling: a case report and review of the literature. | Front Immunol | 2023 | 37153561 | PubTator, text mining | PubMed |
| Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery. | Biomater Res | 2023 | 37149607 | PubTator, text mining | PubMed |
| EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells. | PLoS Pathog | 2023 | 37146061 | PubTator, text mining | PubMed |
| GPR35 antagonist CID-2745687 attenuates anchorage-independent cell growth by inhibiting YAP/TAZ activity in colorectal cancer cells. | Front Pharmacol | 2023 | 37113762 | PubTator, text mining | PubMed |
| Hybrid De Novo Whole-Genome Assembly, Annotation, and Identification of Secondary Metabolite Gene Clusters in the Ex-Type Strain of Chrysosporium keratinophilum. | J Fungi (Basel) | 2023 | 37108844 | PubTator, text mining | PubMed |
| Systematic identification of CRISPR off-target effects by CROss-seq. | Protein Cell | 2023 | 37084235 | PubTator, text mining | PubMed |
| Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors. | Mol Cancer Ther | 2023 | 37070927 | PubTator, text mining | PubMed |
| Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications. | Biomark Res | 2023 | 37069649 | PubTator, text mining | PubMed |
| Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice. | Nat Biomed Eng | 2023 | 37069266 | PubTator, text mining | PubMed |
| Acinetobacter baumannii adaptation to the host pH microenvironment is mediated by allelic variation in a single residue of BauA protein. | PNAS Nexus | 2023 | 37065616 | PubTator, text mining | PubMed |
| Deciphering the complete human-monkeypox virus interactome: Identifying immune responses and potential drug targets. | Front Immunol | 2023 | 37051239 | PubTator, text mining | PubMed |
| Association between Phytochemical Index and Osteoporosis in Women: A Prospective Cohort Study in Korea. | Nutrients | 2023 | 37049447 | PubTator, text mining | PubMed |
| Improved Food-Processing Techniques to Reduce Isoflavones in Soy-Based Foodstuffs. | Foods | 2023 | 37048361 | PubTator, text mining | PubMed |
| The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology. | Int J Mol Sci | 2023 | 37047140 | PubTator, text mining | PubMed |
| Control of human pancreatic beta cell kinome by glucagon-like peptide-1 receptor biased agonism. | Diabetes Obes Metab | 2023 | 37039251 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Prime editing with genuine Cas9 nickases minimizes unwanted indels. | Nat Commun | 2023 | 36997524 | PubTator, text mining | PubMed |
| DNA methylation and cardiovascular disease in humans: a systematic review and database of known CpG methylation sites. | Clin Epigenetics | 2023 | 36991458 | PubTator, text mining | PubMed |
| Forward Genetics-Based Approaches to Understanding the Systems Biology and Molecular Mechanisms of Epilepsy. | Int J Mol Sci | 2023 | 36982355 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2046/papers?page=8